The Killing Drugs: Synthetic Opioids around the World

I n t he final episode of The Killing Drugs , host Vanda Felbab -Brown speaks with Dr. Lisa Durette and Dr. Alexis Kennedy of the University of Nevada , Las Vegas , about the impact of the fentanyl and opioid epidemics on young people. They explore risk factors leading to substance use disorders among the young, including developmental vulnerabilities, the social environment, and trauma and abuse....

In this episode, Vanda Felbab-Brown discusses the fentanyl and opioid crisis in Nevada with Dr. Anne Weisman and Dr. Sara Hunt of the University of Nevada, Las Vegas (UNLV). They analyze the high rates of opioid misuse in the state and the resulting strain on health systems and behavioral health workers as well as coroners, a professional group essential in responding to drug use, but often neglec...

In this episode of The Killing Drugs, Vanda Felbab-Brown discusses the emerging smuggling and retail of illicit fentanyl in South America with guests Daniel Mejía of Universidad de los Andes and Sara Garc í a of InSight Crime. They explore the sources and networks behind this threat, as well as the factors that mitigate or could amplify it. They also analyze South America's preparedness to respond...

In this episode, host Vanda Felbab-Brown speaks with Dr. Alex Stevens, criminology professor at the University of Sheffield, about the emerging threat of synthetic opioids in Europe, particularly fentanyl and nitazenes. Stevens argues that the greater availability of treatment access and harm reduction programs in Europe than in the United States could reduce the severity of a growing flow of synt...

In this episode of The Killing Drugs, Vanda Felbab-Brown talks with Fred Dews about the role of Mexican criminal groups in the U.S. opioid crisis and U.S-Mexico anti-crime cooperation. She explains how, in addition to dominating fentanyl and methamphetamine production and supply to the United States, the Sinaloa cartel and cartel Jalisco Nueva Generación have expanded their role in other illegal a...

In this episode, the podcast roles are reversed as show host Vanda Felbab-Brown is interviewed by Fred Dews, show producer and multimedia project manager at Brookings, about her research on the evolution of illicit networks and supply chains in China that fuel the U.S. fentanyl and opioid crises. They also discuss the evolution and complexities U.S.-China counter-narcotics cooperation and its pros...

In this episode, host Vanda Felbab-Brown speaks with Philomena Kebec, economic development coordinator for the Bad River tribe, about the particularly devastating impact of the fentanyl epidemic on American Indian and Alaska Native communities. In the United States, Native communities experience the highest drug overdose mortality rates among racial groups, with fatalities far surpassing national...

Host Vanda Felbab-Brown interviews Stanford professor Keith Humphreys about drug decriminalization in San Francisco, Oregon, and British Columbia. They discuss the origins and motivations for the dramatic policy change in 2020; the design of the policies, including the similarities with and differences from the decriminalization policies in Portugal; and the outcomes in the Northwest, including in...

Host Vanda Felbab-Brown talks with RAND researchers Beau Kilmer and Roland Neil about U.S. domestic law enforcement responses to the fentanyl crisis. Kilmer and Neil highlight a decline in drug arrests, particularly for cannabis, in the United States, but note a surge in fentanyl-related seizures. They also discuss various alternatives to incarceration for specific drug-related crimes, including p...

In this episode, host Vanda Felbab-Brown discusses the benefits and limitations of harm reduction approaches with experts Regina LaBelle and David Holtgrave, who discuss a wide scope of harm reduction measures, including naloxone provision, overdose prevention centers, and the importance and efficacy of client-centered and community-centered approaches. Felbab-Brown, LaBelle, and Holtgrave also ex...

Host Vanda Felbab-Brown speaks with Dr. Nicole Gastala and Dr. Harold Pollack about the challenges in reducing opioid use disorder in the U.S. They discuss the effectiveness of medication-assisted treatment and explore barriers like stigma, socioeconomic disparities, rural access issues, and insufficient insurance coverage. The conversation emphasizes the need to expand Medicaid, build family supp...

In the show's second episode, host Vanda Felbab-Brown talks with Dr. Peter Reuter and Dr. Greg Midgette, criminology professors at the University of Maryland, about the current state of the U.S. drug market, discussing changes to U.S. consumption patterns from cocaine to various opioids. The episode also explores the dramatic rise in lethality in the U.S. drug market, not just because of the wides...

In the show's first episode, host Vanda Felbab-Brown speaks with Dr. Jonathan Caulkins, a professor at Carnegie Mellon University, about the unique challenges that synthetic drugs, and particularly synthetic opioids, pose for policy. After laying out the history of drug use in the United States and the origins of the fentanyl epidemic, they discuss the pros and cons of a wide range of policies—fro...

Over 100,000 Americans are dying of drug overdoses annually. On The Killing Drugs: Synthetic Opioids around the World , host Vanda Felbab-Brown, a senior fellow in Foreign Policy at the Brookings Institution, interviews leading experts on the devastating synthetic opioid crisis to find policies that can save lives in the United States and around the world. Brought to you by the  Brookings Podcast...